LFMD — LifeMD, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 948320 ·
Last close
$1.79
Market Cap
$86.76M
52W High
$5.38
52W Low
$1.60
ADV30
1,072,540
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 44,625,086 | 36,375,617 | -4,466,501 | -4,469,713 | 66,285,031 | 21,921,769 | 66,864,686 |
| Jun 2026 | 47,281,085 | 41,996,762 | -7,129,601 | -7,083,941 | 59,892,898 | 25,141,615 | 51,926,443 |
| Mar 2026 | 50,162,956 | 44,237,457 | -8,929,072 | -8,872,596 | 70,124,668 | 34,478,137 | 55,087,822 |
| Dec 2025 | 7,080,159 | 2,847,884 | -6,223,260 | 19,963,665 | 70,411,319 | 36,786,318 | 47,254,739 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,769,154
Investing CF
$-8,368,359
Financing CF
$-10,188,427
CapEx
$-11,848,116
Dividends Paid
$-3,106,250
Buybacks
—
EPS Diluted TTM
$-0.05
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-246,112,737
Inventory
$2,956,144
Receivables
$11,256,158
ST Investments
—
EBIT TTM
$-25,406,998
Pretax Income TTM
$-25,376,527
Interest Exp TTM
$686,792
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$189,242,352
EBITDA
$-19,626,152
Free Cash Flow
$-10,605,889
Enterprise Value
$90,022,816
Total Cash
$21,921,768
Total Debt
$5,851,673
Shares Out
48,333,837
Trailing EPS
$-0.52
Book Value
$-0.01
ROE
-1492.5%
ROA
-19.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 194,055,198 | -7,669,694 | 14,354,106 | 70,411,319 | 47,254,739 | 23,156,580 | 8,280,175 |
| Dec 2024 | 154,824,075 | -20,401,988 | -21,409,016 | 76,096,297 | 83,650,417 | -9,083,214 | 17,513,190 |
| Dec 2023 | 152,547,006 | -14,489,273 | -20,595,992 | 58,480,709 | 52,914,550 | 3,505,372 | 8,820,232 |
| Dec 2022 | 119,033,520 | -39,686,185 | -45,535,659 | 25,665,853 | 32,971,356 | -6,829,955 | -22,935,149 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$59,892,898
Forward EPS
$0.41
Max Pain — expiry 2027-05-21
max pain strike: $2.00 · spot: $1.70 · call oi: 744 · put oi: 30,067
Expected Move to 2027-05-21:
±$1.07
(63.24%) —
implied range
$0.62 –
$2.77
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XGN | EXAGEN INC. | $95.93M | $3.76 | — |
| SERA | SERA PROGNOSTICS, INC. | $77.60M | $2.00 | — |
| BDSX | BIODESIX INC | $98.47M | $8.88 | — |
| PARK | Park Dental Partners, Inc. | $107.16M | $19.36 | — |
| BNR | Burning Rock Biotech Ltd | $110.17M | $12.50 | — |
News headlines (Yahoo Finance, 1h cache)
LifeMD: 3 Key Takeaways for Long-Term Investors
2026-11-15 03:06 · Yahoo
LifeMD (LFMD) Q3 2026 Earnings Call Transcript
2026-11-13 15:29 · Yahoo
LifeMD, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
What LifeMD (LFMD) Said on Its Q3 Earnings Call
2026-11-12 23:14 · Yahoo
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates
2026-11-12 22:05 · Yahoo
LifeMD Reports Third Quarter 2026 Results
2026-11-12 21:05 · Yahoo
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
2026-11-07 00:25 · Yahoo
LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide
2026-11-05 12:30 · Yahoo
LifeMD to Report Third Quarter 2026 Financial Results on November 9
2026-10-20 20:05 · Yahoo
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
2026-09-22 21:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.